140 related articles for article (PubMed ID: 20565474)
1. Biological study of the angiogenesis inhibitor N-(8-(3-ethynylphenoxy)octyl-1-deoxynojirimycin.
Zhao Y; Zhou Y; O' Boyle KM; Murphy PV
Chem Biol Drug Des; 2010 Jun; 75(6):570-7. PubMed ID: 20565474
[TBL] [Abstract][Full Text] [Related]
2. Hybrids of 1-deoxynojirimycin and aryl-1,2,3-triazoles and biological studies related to angiogenesis.
Zhao Y; Zhou Y; O'Boyle KM; Murphy PV
Bioorg Med Chem; 2008 Jun; 16(12):6333-7. PubMed ID: 18504133
[TBL] [Abstract][Full Text] [Related]
3. Hybrid angiogenesis inhibitors: synthesis and biological evaluation of bifunctional compounds based on 1-deoxynojirimycin and aryl-1,2,3-triazoles.
Zhou Y; Zhao Y; O' Boyle KM; Murphy PV
Bioorg Med Chem Lett; 2008 Feb; 18(3):954-8. PubMed ID: 18166456
[TBL] [Abstract][Full Text] [Related]
4. N-(8-(3-ethynylphenoxy)octyl-1-deoxynojirimycin suppresses growth and migration of human lung cancer cells.
Zhao Y; Liu W; Zhou Y; Zhang X; Murphy PV
Bioorg Med Chem Lett; 2010 Dec; 20(24):7540-3. PubMed ID: 21036045
[TBL] [Abstract][Full Text] [Related]
5. The alpha-glucosidase I inhibitor castanospermine alters endothelial cell glycosylation, prevents angiogenesis, and inhibits tumor growth.
Pili R; Chang J; Partis RA; Mueller RA; Chrest FJ; Passaniti A
Cancer Res; 1995 Jul; 55(13):2920-6. PubMed ID: 7540952
[TBL] [Abstract][Full Text] [Related]
6. Homonojirimycin isomers and N-alkylated homonojirimycins: structural and conformational basis of inhibition of glycosidases.
Asano N; Nishida M; Kato A; Kizu H; Matsui K; Shimada Y; Itoh T; Baba M; Watson AA; Nash RJ; Lilley PM; Watkin DJ; Fleet GW
J Med Chem; 1998 Jul; 41(14):2565-71. PubMed ID: 9651160
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and biological characterisation of novel N-alkyl-deoxynojirimycin alpha-glucosidase inhibitors.
Rawlings AJ; Lomas H; Pilling AW; Lee MJ; Alonzi DS; Rountree JS; Jenkinson SF; Fleet GW; Dwek RA; Jones JH; Butters TD
Chembiochem; 2009 Apr; 10(6):1101-5. PubMed ID: 19294724
[TBL] [Abstract][Full Text] [Related]
8. Biological properties of D- and L-1-deoxyazasugars.
Kato A; Kato N; Kano E; Adachi I; Ikeda K; Yu L; Okamoto T; Banba Y; Ouchi H; Takahata H; Asano N
J Med Chem; 2005 Mar; 48(6):2036-44. PubMed ID: 15771446
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of the tyrosine phosphatase SHP-2 suppresses angiogenesis in vitro and in vivo.
Mannell H; Hellwig N; Gloe T; Plank C; Sohn HY; Groesser L; Walzog B; Pohl U; Krotz F
J Vasc Res; 2008; 45(2):153-63. PubMed ID: 17962719
[TBL] [Abstract][Full Text] [Related]
10. PTHrP signaling targets cyclin D1 and induces osteoblastic cell growth arrest.
Datta NS; Chen C; Berry JE; McCauley LK
J Bone Miner Res; 2005 Jun; 20(6):1051-64. PubMed ID: 15883646
[TBL] [Abstract][Full Text] [Related]
11. Biological study of a somatostatin mimetic based on the 1-deoxynojrimycin scaffold.
Zhao Y; Liu M; Chagnault V; Wang J; Zhang X; Murphy PV
Bioorg Med Chem Lett; 2011 Jan; 21(2):824-8. PubMed ID: 21194941
[TBL] [Abstract][Full Text] [Related]
12. 4-Aryl-1,2,3-triazole: a novel template for a reversible methionine aminopeptidase 2 inhibitor, optimized to inhibit angiogenesis in vivo.
Kallander LS; Lu Q; Chen W; Tomaszek T; Yang G; Tew D; Meek TD; Hofmann GA; Schulz-Pritchard CK; Smith WW; Janson CA; Ryan MD; Zhang GF; Johanson KO; Kirkpatrick RB; Ho TF; Fisher PW; Mattern MR; Johnson RK; Hansbury MJ; Winkler JD; Ward KW; Veber DF; Thompson SK
J Med Chem; 2005 Sep; 48(18):5644-7. PubMed ID: 16134930
[TBL] [Abstract][Full Text] [Related]
13. Ochnaflavone inhibits TNF-alpha-induced human VSMC proliferation via regulation of cell cycle, ERK1/2, and MMP-9.
Suh SJ; Jin UH; Kim SH; Chang HW; Son JK; Lee SH; Son KH; Kim CH
J Cell Biochem; 2006 Dec; 99(5):1298-307. PubMed ID: 16795041
[TBL] [Abstract][Full Text] [Related]
14. Treatment of hepatitis B virus-infected cells with alpha-glucosidase inhibitors results in production of virions with altered molecular composition and infectivity.
Lazar C; Durantel D; Macovei A; Zitzmann N; Zoulim F; Dwek RA; Branza-Nichita N
Antiviral Res; 2007 Oct; 76(1):30-7. PubMed ID: 17548120
[TBL] [Abstract][Full Text] [Related]
15. Ruboxistaurin, a PKCbeta inhibitor, inhibits retinal neovascularization via suppression of phosphorylation of ERK1/2 and Akt.
Nakamura S; Chikaraishi Y; Tsuruma K; Shimazawa M; Hara H
Exp Eye Res; 2010 Jan; 90(1):137-45. PubMed ID: 19825373
[TBL] [Abstract][Full Text] [Related]
16. Modulation of vascular smooth muscle cell growth by magnesium-role of mitogen-activated protein kinases.
Touyz RM; Yao G
J Cell Physiol; 2003 Dec; 197(3):326-35. PubMed ID: 14566962
[TBL] [Abstract][Full Text] [Related]
17. Nectrisine is a potent inhibitor of alpha-glucosidases, demonstrating activities similarly at enzyme and cellular levels.
Tsujii E; Muroi M; Shiragami N; Takatsuki A
Biochem Biophys Res Commun; 1996 Mar; 220(2):459-66. PubMed ID: 8645327
[TBL] [Abstract][Full Text] [Related]
18. A selective estrogen receptor modulator inhibits TNF-alpha-induced apoptosis by activating ERK1/2 signaling pathway in vascular endothelial cells.
Yu J; Eto M; Akishita M; Okabe T; Ouchi Y
Vascul Pharmacol; 2009 Jul; 51(1):21-8. PubMed ID: 19275968
[TBL] [Abstract][Full Text] [Related]
19. Ferulic acid inhibits endothelial cell proliferation through NO down-regulating ERK1/2 pathway.
Hou Y; Yang J; Zhao G; Yuan Y
J Cell Biochem; 2004 Dec; 93(6):1203-9. PubMed ID: 15486966
[TBL] [Abstract][Full Text] [Related]
20. Miglustat (NB-DNJ) works as a chaperone for mutated acid beta-glucosidase in cells transfected with several Gaucher disease mutations.
Alfonso P; Pampín S; Estrada J; Rodríguez-Rey JC; Giraldo P; Sancho J; Pocoví M
Blood Cells Mol Dis; 2005; 35(2):268-76. PubMed ID: 16039881
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
